Pharmacokinetic study in pigs and in vitro metabolic characterization in pig- and human-liver microsomes reveal marked differences in disposition and metabolism of tiletamine and zolazepam (Telazol)

References

• Bader A, De Bartolo L, Haverich A. (2000). High level benzodiazepine and ammonia clearance by flat membrane bioreactors with porcine liver cells. J Biotechnol 25:95–105
   Google Scholar
• Behnia K, Bhatia S, Jastromb N, et al. (2000). Xenobiotic metabolism by cultured primary porcine hepatocytes. Tissue Eng 6:467–79
   PubMedGoogle Scholar
• Belant JL. (2004). Field immobilization of raccoons (Procyon lotor) with Telazol and xylazine. J Wild Dis 40:787–90
   PubMed Web of Science ®Google Scholar
• Chung H, Choi H, Kim E, et al. (2000). A fatality due to injection of tiletamine and zolazepam. J Anal Toxicol 24:305–8
   PubMed Web of Science ®Google Scholar
• Cording CJ, DeLuca R, Camporese T, Spratt E. (1999). A fatality related to the veterinary anesthetic telazol. J Anal Toxicol 23:552–5
   PubMed Web of Science ®Google Scholar
• Geisslinger G, Hering W, Thomann P, et al. (1993). Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth 70:666–71
   PubMed Web of Science ®Google Scholar
• Hijazi Y, Boulieu R. (2002). Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 30:853–8
   PubMed Web of Science ®Google Scholar
• Ihmsen H, Geisslinger G, Schüttler J. (2001). Stereoselective pharmacokinetics of ketamine: R(−)-ketamine inhibits the elimination of S(+)-ketamine. Clin Pharmacol Ther 70:431–8
   PubMed Web of Science ®Google Scholar
• Jung F, Richardson TH, Raucy JL, Johnson EF. (1997). Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases. Drug Metab Dispos 25:133–9
   PubMed Web of Science ®Google Scholar
• Kaka JS, Hayton WL. (1980). Pharmacokinetics of ketamine and two metabolites in the dog. J Pharmacokinet Biopharm 8:193–202
   PubMedGoogle Scholar
• Kharasch ED, Labroo R. (1992). Metabolism of ketamine stereoisomers by human liver microsomes. Anesthesiology 77:1201–7
   PubMed Web of Science ®Google Scholar
• Kumar A, Mann HJ, Remmel RP. (2006a). Pharmacokinetics of tiletamine and zolazepam (Telazol) in anesthetized pigs. J Vet Pharmacol Ther 29:587–9
   PubMed Web of Science ®Google Scholar
• Kumar A, Mann HJ, Remmel RP. (2006b). Determination of constituents of Telazol®-tiletamine and zolazepam by a gas chromatography/mass spectrometry-based method. J Chromatogr B Analyt Technol Biomed Life Sci 842:131–5
   PubMed Web of Science ®Google Scholar
• Lexcen DR, Lusczek ER, Witowski NE, et al. (2012). Metabolomics classifies phase of care and identifies risk for mortality in a porcine model of multiple injuries and hemorrhagic shock. J Trauma Acute Care Surg 73:S147–55
   Web of Science ®Google Scholar
• Lin HC, Thurmon JC, Benson GJ, Tranquilli WJ. (1993). Telazol -- a review of its pharmacology and use in veterinary medicine. J Vet Pharmacol Ther 16:383–418
   PubMed Web of Science ®Google Scholar
• Miller BF, Muller LI, Storms TN, et al. (2003). A comparison of carfentanil/xylazine and Telazol/xylazine for immobilization of whitetailed deer. J Wild Dis 39:851–8
   PubMed Web of Science ®Google Scholar
• Mion G, Villevieille T. (2013). Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther 19:370–80
   PubMed Web of Science ®Google Scholar
• Natalini CC, Alves SD, Guedes AG, et al. (2004). Epidural administration of tiletamine/zolazepam in horses. Vet Anaesth Analg 31:79–85
   PubMed Web of Science ®Google Scholar
• Nelson MH, Birnbaum AK, Remmel RP. (2001). Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors. Epilepsy Res 44:71–82
   PubMed Web of Science ®Google Scholar
• Pypendop BH, Ilkiw JE. (2005). Pharmacokinetics of ketamine and its metabolite, norketamine, after intravenous administration of a bolus of ketamine to isoflurane-anesthetized dogs. Am J Vet Res 66:2034–8
   PubMed Web of Science ®Google Scholar
• Quail MT, Weimersheimer P, Woolf AD, Magnani B. (2001). Abuse of telazol: an animal tranquilizer. J Toxicol Clin Toxicol 39:399–402
   PubMed Web of Science ®Google Scholar
• Redmond AH, Herman MI. (2002). Ingestion of Telazol®, a veterinary anaesthetic, by a 16 year-old male. Clin Inten Care 13:139–42
   Google Scholar
• Remmel RP, Sinz MW. (1991). A quaternary ammonium glucuronide is the major metabolite of lamotrigine in guinea pigs. In vitro and in vivo studies. Drug Metab Dispos 19:630–6
   PubMed Web of Science ®Google Scholar
• Semple HA, Gorecki DK, Farley SD, Ramsay MA. (2000). Pharmacokinetics and tissue residues of Telazol in free-ranging polar bears. J Wildl Dis 36:653–62
   PubMed Web of Science ®Google Scholar
• Stirling I, Spencer C, Andriashek D. (1989). Immobilization of polar bears (Ursus maritimus) with Telazol in the Canadian Arctic. J Wildl Dis 25:159–68
   PubMed Web of Science ®Google Scholar
• Telazol® package insert; Pfizer Animal Health/Zoetis. Available from: https://online.zoetis.com/US/EN/MSDS_PI/PI/Telazol.pdf [last accessed 3 August 2013]
   Google Scholar
• United States Food and drug administration. Guidance for industry: fixed dose combinations, co-packaged drug products, and single-entity versions of previously approved antiretrovirals for the treatment of HIV. October 2006. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079742.pdf [last accessed 18 June 2013]
   Google Scholar
• Valadon P, Dansette PM, Girault JP, et al. (1996). Thiophene sulfoxides as reactive metabolites: formation upon microsomal oxidation of a 3-aroylthiophene and fate in the presence of nucleophiles in vitro and in vivo. Chem Res Toxicol 9:1403–13
   PubMed Web of Science ®Google Scholar
• Walter WD, Leslie DM Jr, Herner-Thogmartin JH, et al. (2005). Efficacy of immobilizing free-ranging elk with Telazol and xylazine hydrochloride using transmitter-equipped darts. J Wildl Dis 41:395–400
   Google Scholar
• Yanagihara Y, Kariya S, Ohtani M, et al. (2001). Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 29:887–90
   PubMed Web of Science ®Google Scholar
• Yang TJ, Shou M, Korzekwa KR, et al. (1998a). Role of cDNA-expressed human cytochromes P450 in the metabolism of diazepam. Biochem Pharmacol 55:889–96
   PubMed Web of Science ®Google Scholar
• Yang TJ, Krausz KW, Shou M, et al. (1998b). Inhibitory monoclonal antibody to human cytochrome P450 2B6. Biochem Pharmacol 55:1633–40
   PubMed Web of Science ®Google Scholar
• Yasumori T, Li QH, Yamazoe Y, et al. (1994). Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4′-hydroxylation. Pharmacogenetics 4:323–31
   PubMedGoogle Scholar